Advertisement

  • Our Own Words

    People with cancer and their loved ones find ways for their voices to be heard without filters.

    by Bradley Jones

  • Survivor Profile

    Still in the Game

    ESPN reporter Holly Rowe worked through melanoma treatment.

    by Lindsey Konkel

  • Q&A

    Dissecting Mental Illness

    Neuroscientist Barbara Lipska describes her experiences with symptoms of psychiatric illness caused by treatment for metastases in her brain.

    by Marci A. Landsmann

  • Pembrolizumab Shows Further Promise for Melanoma

    In a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected.

    by Brad Jones

  • Forward Look

    Tackling Drug Resistance

    Researchers are studing new ways to keep treatments working longer.

    by Stephen Ornes

  • Survivor Profile

    Living in the Here and Now

    A metastatic melanoma survivor is hopeful but realistic as new treatments become available.

    by Jenny Song

  • Forward Look

    Cancer Immunotherapies Continue to Make Headway

    Drugs that harness the power of the immune system gain new approvals.

    by Alexandra Goho

  • Survivor Profile

    Knowing Her Options

    When Christina McEvoy was diagnosed with stage IV melanoma, she took the reins of her care, traveling more than 600 miles for treatment and returning home to help other melanoma survivors.

    by Melissa Davlin

  • First Person

    Keeping Sight of Hope

    A survivor keeps an eye on what's ahead after a rare cancer diagnosis.

    by Sue Russell

  • Forward Look

    Boosting Defenses Against Cancer

    Q&A with immunologist James P. Allison, Memorial Sloan-Kettering Cancer Center, New York City.

    by Ingfei Chen

Advertisement
Advertisement

From the AACR

  • Targeting KRAS

    After decades of failed efforts to target the elusive KRAS, encouraging data suggest KRAS could finally be dethroned from the “undruggable” category.

  • New FDA Approval

    The U.S. Food and Drug Administration has approved an ovarian cancer treatment based on new biomarker.

  • Advances in Lung Cancer Research and Treatment

    Lung cancer—one of the most commonly diagnosed cancers in the United States—is an area of intense research and clinical development.

Advertisement

Video

Follow My Lead

Advertisement

social media

donate to the AACR